Search Results - "Halik, Paweł"

Refine Results
  1. 1

    Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers by Koźmiński, Przemysław, Halik, Paweł Krzysztof, Chesori, Raphael, Gniazdowska, Ewa

    “…Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively used drugs for treating many kinds of cancer or severe and…”
    Get full text
    Journal Article
  2. 2

    Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine by Halik, Paweł Krzysztof, Koźmiński, Przemysław, Gniazdowska, Ewa

    Published in Molecular pharmaceutics (04-01-2021)
    “…Methotrexate is a gold standard among disease modifying antirheumatic drugs and is also extensively used clinically in combination with oncological therapies…”
    Get full text
    Journal Article
  3. 3

    The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy by Majkowska-Pilip, Agnieszka, Halik, Paweł Krzysztof, Gniazdowska, Ewa

    Published in Pharmaceutics (01-09-2019)
    “…To date, our understanding of the Substance P (SP) and neurokinin 1 receptor (NK1R) system shows intricate relations between human physiology and disease…”
    Get full text
    Journal Article
  4. 4

    Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of 99mTc-Labelled Methotrexate by Koźmiński, Przemysław, Halik, Paweł Krzysztof, Chesori, Raphael, Gniazdowska, Ewa

    Published in Molecules (Basel, Switzerland) (27-09-2021)
    “…The aim of the work carried out was to draw attention to shortcomings that often appear at the stage of designing new radiopharmaceuticals. Based on a case…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The selective response of a templated polymer for the cationic drug pentamidine: implications from molecular simulations and experimental data by Sobiech, Monika, Luliński, Piotr, Halik, Paweł, Maciejewska, Dorota

    Published in RSC advances (2017)
    “…In this paper, we present an analysis of the surface modifications responsible for the selectivity of a new imprinted sorbent produced for the isolation of…”
    Get full text
    Journal Article
  7. 7

    In Vitro Biological Evaluation of Aprepitant Based 177Lu-Radioconjugates by Halik, Paweł K., Koźmiński, Przemysław, Matalińska, Joanna, Lipiński, Piotr F. J., Misicka, Aleksandra, Gniazdowska, Ewa

    Published in Pharmaceutics (10-03-2022)
    “…Currently, the search for promising NK1R-positive tumor-targeting radiopharmaceuticals based on the structure of small molecular antagonists of neurokinin-1…”
    Get full text
    Journal Article
  8. 8

    In Vitro Biological Evaluation of Aprepitant Based 177 Lu-Radioconjugates by Halik, Paweł K, Koźmiński, Przemysław, Matalińska, Joanna, Lipiński, Piotr F J, Misicka, Aleksandra, Gniazdowska, Ewa

    Published in Pharmaceutics (10-03-2022)
    “…Currently, the search for promising NK1R-positive tumor-targeting radiopharmaceuticals based on the structure of small molecular antagonists of neurokinin-1…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A165/NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic by Masłowska, Katarzyna, Witkowska, Ewa, Tymecka, Dagmara, Halik, Paweł Krzysztof, Misicka, Aleksandra, Gniazdowska, Ewa

    Published in Pharmaceutics (01-01-2022)
    “…Neuropilin-1 (NRP-1) is a surface receptor found on many types of cancer cells. The overexpression of NRP-1 and its interaction with vascular endothelial…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy by Masłowska, Katarzyna, Halik, Paweł Krzysztof, Tymecka, Dagmara, Misicka, Aleksandra, Gniazdowska, Ewa

    Published in Cancers (03-03-2021)
    “…One approach to anticancer treatment is targeted anti-angiogenic therapy (AAT) based on prevention of blood vessel formation around the developing cancer…”
    Get full text
    Journal Article
  13. 13

    Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors by Halik, Paweł K, Lipiński, Piotr F J, Matalińska, Joanna, Koźmiński, Przemysław, Misicka, Aleksandra, Gniazdowska, Ewa

    Published in Molecules (Basel, Switzerland) (18-08-2020)
    “…Aprepitant, a lipophilic and small molecular representative of neurokinin 1 receptor antagonists, is known for its anti-proliferative activity on numerous…”
    Get full text
    Journal Article
  14. 14

    New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer’s Disease Research by Koźmiński, Przemysław, Niedziałek, Dorota, Wieczorek, Grzegorz, Halik, Paweł K., Czarnecka, Kamila, Rogut, Aleksandra, Cheda, Łukasz, Rogulski, Zbigniew, Szymański, Paweł, Gniazdowska, Ewa

    “…Viral pneumonia caused by highly infectious SARS-CoV-2 poses a higher risk to older people and those who have underlying health conditions, including…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A 165 /NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic by Masłowska, Katarzyna, Witkowska, Ewa, Tymecka, Dagmara, Halik, Paweł Krzysztof, Misicka, Aleksandra, Gniazdowska, Ewa

    Published in Pharmaceutics (01-01-2022)
    “…Neuropilin-1 (NRP-1) is a surface receptor found on many types of cancer cells. The overexpression of NRP-1 and its interaction with vascular endothelial…”
    Get full text
    Journal Article
  19. 19
  20. 20